Savara (SVRA) Stock Insights

SVRA price $5.02 +0.16 +3.29%

Ticker
SVRA
Price
$5.02
Change
+0.16 +3.29%
Market cap ?
$1.03B
P/E ?
-7.48
Forward P/E ?
110.02
Dividend yield ?
0.00%
Beta ?
0.25
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
67
Value
54
Quality
47
Growth
100

Stocklytics score rationale: value 54, quality 47, growth 100.

Financials

2016201720182019202020212022202320242025
40000000025700000000

Savara Inc. is a biopharmaceutical firm in the clinical development phase, specializing in therapies for uncommon respiratory conditions. Their primary investigational drug, molgramostim, is an inhaled form of granulocyte-macrophage colony-stimulating factor (GM-CSF). This compound is currently undergoing Phase III trials to address autoimmune pulmonary alveolar proteinosis. The company's main operations are…

Fair value

SVRA fair value $1.17. Price $5.02. Price is 330% above fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare SVRA

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-11—-0.16—500.00K
2026-08-11-0.16-0.14—2.00M
2026-05-12-0.15-0.14—500.00K
2026-03-13-0.13-0.12——
2025-11-12-0.14-0.13——
2025-08-13-0.14-0.12——
2025-05-13-0.12-0.12——
2025-03-27-0.13-0.11272.00K—
2024-11-12-0.11-0.11——
2024-08-12-0.12-0.11——
2024-05-09-0.11-0.10——
2024-03-07-0.09-0.11——
2023-11-09-0.10-0.07——
2023-08-10-0.07-0.08——
2023-05-15-0.07-0.07——
2023-03-30-0.07-0.08——
2022-11-10-0.07-0.07——
2022-08-11-0.06-0.06——
2022-05-11-0.05-0.08——
2022-03-30-0.07-0.07——
2021-11-12-0.07-0.09——
2021-08-12-0.07-0.12——
2021-05-13-0.13-0.08——
2021-03-10-0.23-0.101.00K—
2020-11-05-0.18-0.20256.00K241.78K
2020-08-06-0.16-0.20——
2020-05-07-0.27-0.28——
2020-03-12-0.28-0.31——
2019-11-07-0.30-0.44——
2019-08-08-0.38-0.43——
2019-05-09-0.34-0.39——
2019-03-13-0.29-0.37——
2018-11-07-0.37-0.34——
2018-08-09-0.38-0.34——
2018-05-09-0.32-0.31——
2018-03-14-0.23-0.2394.00K—
2017-11-08-0.28-0.40——
2017-08-09-0.90-0.26——
2017-05-09-1.61—94.00K—
2017-03-06-0.70-2.8083.00K320.00K

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-24Parker Braden C.Sell29.32K$5.07148.67K
2026-07-15Lutz Robert MatthewBuy35.00K——
2026-07-15Lutz Robert MatthewBuy70.00K$5.81406.70K
2026-06-22Lowrance David LBuy87.65K$3.35293.63K
2026-06-22Lowrance David LBuy218.75K$1.51330.31K
2026-06-22Lowrance David LSell53.39K$5.50293.63K
2026-06-22Lowrance David LBuy12.50K$4.4555.62K
2026-06-22Lowrance David LSell10.11K$5.5055.63K
2026-06-22Lowrance David LSell60.06K$5.50330.31K
2026-06-22Lowrance David LBuy56.94K$1.1163.20K
2026-06-22Lowrance David LSell11.49K$5.5063.20K
2026-06-22Lowrance David LBuy129.35K$1.23159.10K
2026-06-22Lowrance David LSell28.93K$5.50159.10K
2026-06-22Lowrance David LBuy75.00K$1.59119.25K
2026-06-22Lowrance David LSell21.68K$5.50119.25K
2026-06-22Lowrance David LSell394.53K$5.682.24M
2026-06-22Lowrance David LSell87.65K$3.35293.63K
2026-06-22Lowrance David LSell218.75K$1.51330.31K
2026-06-22Lowrance David LSell12.50K$4.4555.62K
2026-06-22Lowrance David LSell56.94K$1.1163.20K
2026-06-22Lowrance David LSell129.35K$1.23159.10K
2026-06-22Lowrance David LSell75.00K$1.59119.25K
2026-03-18Lowrance David LBuy24.85K$3.3583.25K
2026-03-18Lowrance David LBuy12.50K$4.4555.62K
2026-03-18Lowrance David LSell16.52K$5.0483.25K
2026-03-18Lowrance David LBuy43.06K$1.1147.80K
2026-03-18Lowrance David LSell11.04K$5.0455.63K
2026-03-18Lowrance David LSell9.48K$5.0447.80K
2026-03-18Lowrance David LBuy130.65K$1.23160.70K
2026-03-18Lowrance David LSell31.89K$5.04160.70K
2026-03-18Lowrance David LBuy75.00K$1.59119.25K
2026-03-18Lowrance David LSell23.66K$5.04119.25K
2026-03-18Lowrance David LBuy80.68K$1.51121.83K
2026-03-18Lowrance David LSell24.17K$5.04121.84K
2026-03-18Lowrance David LSell24.85K$3.3583.25K
2026-03-18Lowrance David LSell130.65K$1.23160.70K
2026-03-18Lowrance David LSell75.00K$1.59119.25K
2026-03-18Lowrance David LSell43.06K$1.1147.80K
2026-03-18Lowrance David LSell12.50K$4.4555.62K
2026-03-18Lowrance David LSell80.68K$1.51121.83K
2026-02-16McCracken Joseph SBuy1.81K$1.763.18K
2026-02-16McCracken Joseph SSell1.81K$1.763.18K
2025-12-19RAMSAY DAVID ASell20.00K$6.06121.22K
2025-12-16Lowrance David LSell32.00K——
2025-12-16Pauls MatthewSell129.00K——
2025-12-14Lowrance David LSell62.96K$6.92435.68K
2025-12-14Pauls MatthewSell195.71K$6.921.35M
2025-12-14Lutz Robert MatthewSell67.76K$6.92468.90K
2025-12-14McCabe Kathleen R.Sell39.35K$6.92272.30K
2025-12-14Erickson AnneSell62.96K$6.92435.68K
2025-12-10Pauls MatthewSell23.63K——
2025-12-09Hawkins Richard JBuy40.00K——
2025-12-09van Es-Johansson AnBuy40.00K——
2025-12-09Elam Nevan CBuy40.00K——
2025-12-09RAMSAY DAVID ABuy40.00K——
2025-12-09McCracken Joseph SBuy40.00K——
2025-12-04Wasfi YasmineSell21.99K$6.37140.09K
2025-12-02Elam Nevan CBuy5.86K$1.468.56K
2025-12-02Elam Nevan CSell1.47K$5.818.56K
2025-12-02Elam Nevan CSell5.86K$1.468.56K
2025-11-14Hawkins Richard JBuy5.86K$1.468.56K
2025-11-14Hawkins Richard JSell5.86K$1.468.56K
2025-10-20Wasfi YasmineBuy35.00K——
2025-10-20Wasfi YasmineBuy70.00K$4.11287.70K
2025-10-17Wasfi YasmineOther0——
2025-10-17Wasfi YasmineOther175.00K$3.35586.25K
2025-10-17Wasfi YasmineOther110.00K$4.13454.30K
2025-06-20Hawkins Richard JBuy48.23K$2.0498.57K
2025-05-29McCracken Joseph SBuy10.00K$2.0820.82K
2025-03-31RAMSAY DAVID ABuy150.00K$2.77416.25K
2025-03-13McCabe Kathleen R.Other0——
2025-03-13McCabe Kathleen R.Other175.00K$3.35586.25K
2025-03-13McCabe Kathleen R.Other30.00K$7.33219.90K
2025-03-13McCabe Kathleen R.Other5.25K$11.0057.75K
2025-03-13McCabe Kathleen R.Other31.25K$1.1134.69K
2025-03-13McCabe Kathleen R.Other34.97K$1.2343.01K
2025-03-13McCabe Kathleen R.Other25.00K$4.45111.25K
2025-03-13McCabe Kathleen R.Other90.12K$1.51136.09K
2025-02-13Lutz Robert MatthewSell38.26K$2.83108.28K
2024-12-16Lowrance David LSell25.00K$3.3383.28K
2024-12-16Pauls MatthewSell54.70K$3.31180.83K
2024-12-16Hawkins Richard JSell8.00K$3.3226.57K
2024-12-13Erickson AnneSell18.26K$3.2158.62K
2024-12-13Lowrance David LSell12.00K——
2024-12-13Lowrance David LSell24.35K$3.2178.16K
2024-12-13Pauls MatthewSell92.59K$3.21297.22K
2024-12-12Erickson AnneBuy100.00K——
2024-12-12Erickson AnneBuy300.00K$3.351.00M
2024-12-12Parker Braden C.Buy20.00K——
2024-12-12Parker Braden C.Buy40.00K$3.35134.00K
2024-12-12Lutz Robert MatthewBuy100.00K——
2024-12-12Lutz Robert MatthewBuy300.00K$3.351.00M
2024-12-12Lowrance David LBuy100.00K——
2024-12-12Lowrance David LBuy300.00K$3.351.00M
2024-12-12Pratt Raymond DennisBuy80.00K——
2024-12-12Pratt Raymond DennisBuy280.00K$3.35938.00K
2024-12-12Pauls MatthewBuy400.00K——
2024-12-12Pauls MatthewBuy900.00K$3.353.02M
2024-12-12Hawkins Richard JBuy40.00K——
2024-12-12Elam Nevan CBuy40.00K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 189, holders -1 vs prior quarter. Ownership 86.09%.

HolderSharesChangeChange %Value
NEA MANAGEMENT COMPANY, LLC24.47M00.00%150.74M
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC17.60M00.00%108.42M
VENROCK ADVISER, LLC14.75M1.01M+7.32%90.84M
DEERFIELD MANAGEMENT COMPANY, L.P.13.57M00.00%83.59M
BLACKROCK, INC.12.49M1.20M+10.66%76.97M
TCG CROSSOVER MANAGEMENT, LLC12.36M00.00%76.15M
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.9.72M00.00%59.88M
POLAR CAPITAL HOLDINGS PLC9.54M00.00%58.78M
VANGUARD CAPITAL MANAGEMENT LLC7.93M148.63K+1.91%48.86M
NANTAHALA CAPITAL MANAGEMENT, LLC6.98M-367.97K-5.01%42.98M
STATE STREET CORP6.55M-154.34K-2.30%40.37M
MARSHALL WACE, LLP6.26M1.74M+38.60%38.54M
RTW INVESTMENTS, LP5.95M00.00%36.67M
WOODLINE PARTNERS LP4.25M00.00%26.15M
ORBIMED ADVISORS LLC3.96M3.32M+523.61%24.39M
GEODE CAPITAL MANAGEMENT, LLC3.87M277.65K+7.72%23.86M
SPRUCE STREET CAPITAL LP3.45M69.40K+2.05%21.27M
ROSALIND ADVISORS, INC.3.18M-25.60K-0.80%19.58M
EMERALD ADVISERS, LLC3.15M-222.85K-6.61%19.39M
PICTET ASSET MANAGEMENT HOLDING SA2.76M487.67K+21.43%17.02M
VESTAL POINT CAPITAL, LP2.72M119.95K+4.61%16.76M
WELLINGTON MANAGEMENT GROUP LLP2.69M-15.91K-0.59%16.60M
D. E. SHAW & CO., INC.2.51M403.12K+19.09%15.49M
AFFINITY ASSET ADVISORS, LLC2.51M00.00%15.47M
EMERALD MUTUAL FUND ADVISERS TRUST2.38M7.33K+0.31%14.64M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Savara (SVRA) Stock Insights

SVRA$5.02+0.16 +3.29%

$1.03B

Market Cap

-7.48

P/E

110.02

Forward P/E

67

Score

Price History